Background Age-related macular degeneration (AMD) is thought to cause approximately 9%
of all cases of blindness worldwide. In Germany, half of all cases of blindness and high …

Diabetic macular edema (DME) is the most common cause of vision loss in patients with
diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 …

The innate immune landscape of the central nervous system (CNS), including the brain and
the retina, consists of different myeloid cell populations with distinct tasks to fulfill. Whereas …

Purpose: To assess the gap between visual acuity (VA) outcomes with anti-vascular
endothelial growth factor (anti-VEGF) therapies in clinical trials and real-world practice, and …

Intravitreal injections (IVI) of anti–vascular endothelial growth factor (anti–VEGF) agents
have become the most prevalent intraocular procedure as they represent the major …

Müller glia (MG) are major retinal supporting cells that participate in retinal metabolism,
function, maintenance, and protection. During the pathogenesis of diabetic retinopathy (DR) …

Untreated neovascular age-related macular degeneration (nAMD) can lead to severe and
permanent visual impairment. The chronic nature of the disease can have a significant …

Objectives of the Study. Summary of observational studies concerning the pharmacological
management of diabetic macular edema (DME). Methods. A literature review was conducted …

Purpose Dual inhibition of angiopoietin-2 and VEGF-A with faricimab (Vabysmo) offers
excellent visual acuity gains with strong durability in patients with diabetic macular edema …

Recent studies deciphering the transcriptional profile of choroidal neovascularization (CNV)
in body donor eyes with neovascular age-related macular degeneration are limited by the …